共 24 条
[1]
Ramstack M., Grandolfi G., Mannaert E., D'Hoore P., Lasser R.A., Long-acting risperidone: Prolonged-release injectable delivery of risperidone using Medisorb microsphere technology, Schizophrenia Research, 60, SUPPL., (2003)
[2]
Kostanski J.W., Thanoo B.C., DeLuca P.P., Preparation, characterization, and in vitro evaluation of 1- and 4-month controlled release orntide PLA and PLGA microspheres, Pharm. Dev. Technol., 5, pp. 585-596, (2000)
[3]
D'Souza S.S., Selmin F., Murty S.B., Qiu W., Thanoo B.C., DeLuca P.P., Assessment of fertility in male rats after extended chemical castration with a GnRH antagonist, AAPS PharmSci., 6, (2004)
[4]
Woo B.H., Na K.-H., Dani B.A., Jiang G., Thanoo B.C., DeLuca P.P., In vitro characterization and in vivo testosterone suppression of 6-month release poly(D,L-lactide) leuprolide microspheres, Pharm. Res., 19, pp. 546-550, (2002)
[5]
Okada H., Doken Y., Ogawa Y., Toguchi H., Preparation of three-month injectable microspheres of leuprorelin acetate using biodegradable polymers, Pharm. Res., 11, pp. 1143-1147, (1994)
[6]
Kane J.M., Eerdekens M., Lindenmayer J.-P., Keith S.J., Lesem M., Karcher K., Long-acting injectable Risperidone: Efficacy and safety of the first long-acting atypical antipsychotic, Am. J. Psychiatry, 160, pp. 1125-1132, (2003)
[7]
Siewert M., Dressman J., Brown C.K., Shah V.P., FIP/AAPS guidelines to dissolution/in vitro release testing of novel /special dosage forms, AAPS PharmSciTech., 4, (2003)
[8]
Buchholz B., Accelerated degradation test on resorbable polymers, Degradation Phenomena of Polymeric Biomaterials, pp. 67-76, (1992)
[9]
Makino K., Arakawa M., Kondo T., Preparation and in vitro degradation properties of polylactide microcapsules, Chem. Pharm. Bull. (Tokyo), 33, pp. 1195-1201, (1985)
[10]
Bergsma J.E., Rozema F.R., Bos R.R.M., Boering G., Joziasse C.A.P., Pennings A.J., In vitro predegradation at elevated temperatures of poly(lactide), J. Mater. Sci. Mater. Med., 6, pp. 642-646, (1995)